LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

Abstract Background Hypercholesterolemia is a major risk factor for cardiovascular disorders and requires specific intervention through an adequate lifestyle (diet and physical exercise) and, if necessary, an appropriate drug treatment. Lipid-lowering drugs, although generally efficacious, may somet...

Full description

Bibliographic Details
Main Authors: S. Magno, G. Ceccarini, C. Pelosini, R. Jaccheri, J. Vitti, P. Fierabracci, G. Salvetti, G. Airoldi, M. Minale, G. Saponati, F. Santini
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12944-018-0775-8